Ignite Creation Date:
2024-05-06 @ 10:09 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03175887
Status:
WITHDRAWN
Last Update Posted:
2021-05-13
First Post:
2017-05-03
Brief Title:
Investigational TMS Treatment for Depression
Sponsor:
White River Junction Veterans Affairs Medical Center
Organization:
White River Junction Veterans Affairs Medical Center
Study Overview
Official Title:
Dorsolateral Versus Medial Prefrontal TMS for Depression
Status:
WITHDRAWN
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
PIs discretion due to needing to modify study protocol
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is aimed to help us learn about the effects of Transcranial Magnetic Stimulation at the forehead versus the left side of the head for treatment of Treatment Resistant Depression
Detailed Description:
While transcranial magnetic stimulation TMS to the left dorsolateral prefrontal cortex DLPFC is an FDA approved treatment for depression a growing and converging database suggests the medial prefrontal cortex MPFC may be even more critical to the neurobiology of depression and antidepressant treatment response This study will compare the efficacy of high frequency transcranial madntic stimulation on these two sections of the brain
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None